American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 49-57 , July 2008

Waist-to-Hip Ratio and Body Mass Index as Risk Factors for Cardiovascular Events in CKD

  • Essam F. Elsayed, MD, MS

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • ,
  • Hocine Tighiouart, MS

      Affiliations

    • Institute for Clinical Research and Health Policy, Tufts Medical Center, Boston, MA.
    • ,
  • Daniel E. Weiner, MD, MS

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • ,
  • John Griffith, PhD

      Affiliations

    • Institute for Clinical Research and Health Policy, Tufts Medical Center, Boston, MA.
    • ,
  • Deeb Salem, MD

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Mark J. Sarnak, MD, MS, Box 391, Division of Nephrology, Tufts Medical Center, 750 Washington St, Boston, MA 02111.

Received 11 December 2007 ,Accepted 4 April 2008.

References 

  1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  3. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198–206
  4. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745–753
  5. Shlipak MG, Heidenreich PA, Noguchi H, et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555–562
  6. Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA. 2006;295:190–198
  7. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet. 2005;366:1640–1649
  8. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  9. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554
  10. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007;49:581–591
  11. Madero M, Sarnak MJ, Wang X, et al. Body mass index and mortality in CKD. Am J Kidney Dis. 2007;50:404–411
  12. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366–2372
  13. Hsu C, Iribarren C, Go A. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:701–702
  14. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: Evaluation using receiver operating characteristic curves. Am J Clin Nutr. 1998;67:44–49
  15. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379–384
  16. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39–48
  17. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them?. Int J Epidemiol. 2006;35:83–92
  18. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol. 1989;129:687–702
  19. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol. 1991;1:263–276
  20. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920–929
  21. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  22. Kwan BCH, Ramkumar N, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. J Am Soc Nephrol. 2006;17:99A;(abstr)
  23. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central obesity are independently related to mortality in older men. Am J Clin Nutr. 2007;86:1339–1346
  24. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: Opposite (adverse versus favorable) associations with arterial stiffness? (The Amsterdam Growth and Health Longitudinal Study). J Clin Endocrinol Metab. 2004;89:2632–2639
  25. Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem. 2001;276:25096–25100
  26. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res. 2001;88:954–960
  27. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 2001;104:3052–3056
  28. Montague CT, Prins JB, Sanders L, et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes. 1998;47:1384–1391
  29. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 1995;27:435–438
  30. Alessi MC, Peiretti F, Morange P, et al. Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease. Diabetes. 1997;46:860–867
  31. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta. 2000;1500:88–96
  32. Snijder MB, Dekker JM, Visser M, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: The Hoorn Study. Diabetes Care. 2004;27:372–377
  33. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: The Quebec Family Study. Am J Clin Nutr. 2001;74:315–321
  34. Schoen RE, Thaete FL, Sankey SS, Weissfeld JL, Kuller LH. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes Relat Metab Disord. 1998;22:338–342

 Originally published online as doi:10.1053/j.ajkd.2008.04.002 on June 5, 2008.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Bryan Becker, MD, University of Wisconsin) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(08)00739-7

doi: 10.1053/j.ajkd.2008.04.002

American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 49-57 , July 2008

Article Tools

* Image Usage & Resolution